Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Emtricitabine MeSH Descriptor Data 2025


MeSH Heading
Emtricitabine
Tree Number(s)
D03.383.742.680.245.500.600
D13.570.230.329.525
D13.570.685.245.500.600
Unique ID
D000068679
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068679
Scope Note
A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS.
Entry Term(s)
Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
Coviracil
Emtriva
Pharm Action
Antiviral Agents
Reverse Transcriptase Inhibitors
Anti-HIV Agents
Registry Numbers
G70B4ETF4S
0
Public MeSH Note
2016; EMTRICITABINE was indexed under DEOXYCYTIDINE 1999-2015
History Note
2016 (1999)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2016/05/31
Emtricitabine Preferred
Coviracil Narrower
Emtriva Narrower
page delivered in 0.129s